Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2023 Jun 7;3(6):e0001223. doi: 10.1371/journal.pgph.0001223

Health care workers’ self-perceived infection risk and COVID-19 vaccine uptake: A mixed methods study

Kasusu Klint Nyamuryekung’e 1,*, Maryam Amour 2, Innocent Mboya 3,4, Harrieth Ndumwa 2, James Kengia 5, Belinda J Njiro 2, Lwidiko Mhamilawa 6,7, Elizabeth Shayo 8, Frida Ngalesoni 9, Ntuli Kapologwe 5, Albino Kalolo 10, Emmy Metta 11, Sia Msuya 3,4,12
Editor: Edina Amponsah-Dacosta13
PMCID: PMC10246783  PMID: 37285332

Abstract

Vaccination is the most cost-effective way of preventing Coronavirus Disease 2019 (COVID-19) although there was a considerable delay in its institution in Tanzania. This study assessed health care workers’ (HCWs) self-perceived infection risk and uptake of COVID-19 vaccines. A concurrent embedded, mixed methods design was utilized to collect data among HCWs in seven Tanzanian regions. Quantitative data was collected using a validated, pre-piloted, interviewer administered questionnaire whereas in-depth interviews (IDIs) and focus group discussions (FGDs) gathered qualitative data. Descriptive analyses were performed while chi-square test and logistic regression were used to test for associations across categories. Thematic analysis was used to analyze the qualitative data. A total of 1,368 HCWs responded to the quantitative tool, 26 participated in the IDIs and 74 in FGDs. About half of the HCW (53.6%) reported to have been vaccinated and three quarters (75.5%) self-perceived to be at a high risk of acquiring COVID-19 infection. High perceived infection risk was associated with increased COVID-19 vaccine uptake (OR 1.535). Participants perceived that the nature of their work and the working environment in the health facilities increased their infection risk. Limited availability and use of personal protective equipment (PPE) was reported to elevate the perceived infection risks. Participants in the oldest age group and from low and mid-level health care facilities had higher proportions with a high-risk perception of acquiring COVID-19 infection. Only about half of the HCWs reported to be vaccinated albeit the majority recounted higher perception of risk to contracting COVID-19 due to their working environment, including limited availability and use of PPE. Efforts to address heightened perceived-risks should include improving the working environment, availability of PPE and continue updating HCWs on the benefits of COVID-19 vaccine to limit their infection risks and consequent transmission to their patients and public.

Introduction

The novel coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome corona virus 2 (SARs-CoV-2) remains a significant disease of public health concern. Since its emergence, it has been shown to spread rapidly causing dramatic global health crisis [1]. It was declared as a pandemic by the World Health Organization (WHO) on the 11th of March 2020 as of April 26th, 2023 there was a total of 764,474,387 confirmed cases and 6,915,286 confirmed deaths globally [2]. Tanzania has reported relatively few number of COVID-19 cases, with a total of 42,973 confirmed cases and 846 deaths reported between January 2020 and April 26, 2023 [3].

Vaccination is among the most cost-effective ways of preventing diseases. For the vaccination effect to be appreciated, several strategies to be considered include vaccine availability, accessibility, and acceptability of the population to vaccinate. Studies show that about 14.3% and 22.1% of the global population intend to refuse vaccination or showed uncertainty respectively, with higher rates reported in lower income countries [4]. Moreover, perceived vaccine efficacy and safety concerns contribute to the observed trends in most countries [4].

There was a considerable delay in COVID-19 vaccine roll out in Tanzania, after launching the first nation-wide COVID-19 vaccination, the first roll out was made available among priority groups; health care workers (HCWs) with high risk of getting and transmitting the infection, people with advanced age and underlying medical conditions with a high risk of developing severe disease [5]. In Tanzania, a total of 39,392,419 vaccine doses were administered by the 22nd of March, 2023 under COVAX facility [3, 6]. Currently, access to COVID-19 vaccine in Africa has improved; however, vaccines acceptance and hesitancy influenced by social, political, and religious factors may contribute to low vaccine uptake [7, 8].

HCWs stand as among the most important groups as trusted influencers in regards to health issues, including vaccination decisions [7]. This important group should be guided and supported to provide credible and scientifically proven information on vaccines as their influence in the community remains pivotal. It is therefore important to understand and acknowledge HCWs perspectives with regard to COVID-19 vaccines [4]. However, studies have reported a number of challenges facing this population including high risk of infection, insufficient personal protective equipment (PPE), heavy workloads and discrimination [8]. In Tanzania, a national COVID-19 committee was formed in May 2021, which recommended that HCWs be vaccinated as a priority group.

Risk perception, defined as an individual perceived susceptibility to threat, plays a key role in health behavioral change theories, including health decision making process [9]. HCWs are among the most vulnerable groups for SARs-CoV-2 infection, they work in frontline positions with suspected and confirmed COVID-19 cases, 5–7.3% of HCWs were found to be COVID-19 positive in some developed countries [10, 11]. Some studies have reported that perceived risk of COVID-19 infection and detrimental health effects among HCW are associated positive protective behaviors [12]. In Ethiopia, 88% of HCWs were reported to perceive their risk of being infected with COVID-19 infection as high, and showed widespread practice on preventive measures [13].

Myths and misconceptions around the COVID-19 vaccine subject have been circulating and its impact can be observed especially in developing countries [1]. This has been shown to contribute to the observed vaccine hesitancy, which is defined by WHO as “the reluctance in accepting vaccines or an outright refusal of vaccines despite their availability” [7]. WHO has further mentioned vaccine hesitancy as one of the top global threats to public health in 2019 [7, 14]. As reported by a study done in Senegal with 5.5% COVID-19 vaccine coverage, vaccine hesitancy and refusal have contributed to low vaccine uptake despite its multifaceted nature [15]. In Ethiopia, more than 50% of HCWs were found to be vaccine hesitant [4].

While being at an increased risk of COVID-19 infection and disease transmission in Tanzania, HCWs play an influential role in community understanding and overall vaccine uptake; there is paucity of data on the status of vaccine uptake among HCWs and the influencing factors in Tanzania. Understanding HCWs risk perception and their influence on vaccination is crucial in informing policy makers and highlighting educational needs to address the situation especially in developing countries like Tanzania. This mixed method study illustrates on HCWs perceptions in relation to the COVID-19 vaccine uptake situation in Tanzania.

Materials and methods

Study setting

Tanzania is a large East African country with an area of 947,000 square kilometers and an estimated population of 61.5 million (2021 World Bank projections) of which about two-thirds live in rural areas. Tanzania comprises of the much larger mainland and semi-autonomous isles (Zanzibar); the current study was conducted in mainland Tanzania. Mainland Tanzania is administratively divided into 26 regions, each region comprising of a variable number of districts (4–6), which in turn contain wards. The Tanzanian healthcare delivery facilities follow this pyramidal administrative arrangement, with regional referral hospitals situated at the apex, functioning as the highest-level hospital within a region, which receive referrals from district hospitals, that in turn receive patients from lower levels (health centers and dispensaries). Groups of regions are further clustered into six geographical zones (Northern, Coastal, Central, Southern highlands, Western and Lake). One region was randomly selected from each of these six zones to be included in the study. The sampled regions were Kilimanjaro, Lindi, Njombe, Mbeya, Tabora and Simiyu representing Northern, Coastal, Central, Southern highlands, Western and Lake zones, respectively. Dar es salaam was purposively selected to be included because it is the largest city in Tanzania, and the major port of entry to the country from international arrivals. The researchers believed that it is important to capture the HCW population perceptions from a cosmopolitan city.

Study design and participants

A concurrent embedded mixed methods research design was utilized to collect data among HCWs in seven regions of mainland Tanzania from November 2021 to January 2022. The qualitative part of the study was embedded in the quantitative cross-sectional study. The qualitative part was intended to explain the HCWs risk perceptions towards COVID-19 disease, as a supplement of the quantitative study assessing COVID-19 vaccine hesitancy.

Study population from which the sample size was determined included all cadres of HCWs at all levels of healthcare service provision in Tanzania. This included any medical, dental, laboratory, pharmaceutical or nursing staff working in a medical institution as officially registered through their professional associations. A sample size for the quantitative part of the study (N = 1400) was determined by using a single proportion formula taking a standard normal value of 1.96 under the 95% confidence limit, 50% proportion of vaccine hesitancy (for maximization of sample size), 3.5% margin of error, 1.5 design effect to address the clustering effect while adjusting for a non-response rate of 20%.

Multi-stage sampling technique was employed to recruit HCWs from the seven (7) selected regions for the quantitative part. One Regional Referral hospital, two (2) district hospitals and two (2) health centers from each of the identified regions were included in this study. Therefore, a total of seven (7) Regional Referral Hospitals, fourteen (14) district hospitals, and fourteen (14) health centers were included. Systematic sampling technique was used to select healthcare facilities for inclusion. Sampling of HCWs within the selected health facilities was based on their number in the selected health facilities in a region proportional to their size. Upon determination of the respective health facilities’ sample sizes, HCWs were consecutively invited to participate and enrolled into the study. All available HCWs were invited to participate, and interviews carried out until the minimum sample size was reached.

The qualitative component of the study was conducted in four of the seven regions where the quantitative study took place due to resource limitations. In-depth interviews (IDI) were conducted in each region with the key officials including the Regional Medical Officers, Regional Vaccination Officers, District Medical officers, District vaccination officers and Medical Officers In-charge of health facilities leading to a total of 26 interviews. Additionally, we conducted two focus group discussions (FGDs) in each region with participants ranging from 6–12 people leading to a total 74 participants in 8 FGDs. The FGDs engaged HCWs in the selected districts within the study regions.

Data collection tools and procedures

Quantitative data was collected using a validated, pre-piloted questionnaire through the Open Data Kit (ODK). The pilot testing of the study tools was done through a randomly selected group of HCWs from Muhimbili University of Health and Allied Sciences, to whom the link to the ODK tool was shared for testing. Feedback on the shortcomings of the tools was incorporated in the revised final version. The questionnaires were developed based on various studies and WHO proposed questions to assess vaccine hesitancy and acceptability [1623]. The questionnaire was prepared in English, translated in Swahili, and had four components: socio-demographic, awareness and knowledge on COVID-19 vaccines, risk perception towards COVID-19 and COVID-19 vaccination status. The questionnaire contained both closed and open-ended questions for assessment of awareness and knowledge components. Risk perception towards COVID-19 infection was measured on Likert scale. Back translation to English was done to preserve the meaning of the questions. The questionnaire was administered face-face by trained research assistants (RAs). On the day of quantitative data collection, the RAs visited the HCWs, introduced themselves and explained the study purpose. Then, they provided study information to the HCWs and obtained informed consent in a quiet, private place around the health facility. Special emphasis was placed on issues of anonymity and confidentiality, and in assuring the respondents that no personal identifiable information will be collected to encourage truthful responses. Only the consenting individuals were interviewed.

Qualitative data was collected through IDIs and FGDs with purposively selected health officials and HCWs to explore their opinions and risk perceptions towards COVID-19. All interviews were conducted in Swahili and audio recorded with the permission of the study participants. Further, researchers applied the principle of bracketing to ensure that pre-understanding information do not influence the data [24]. Furthermore, for enhancement of reliability, field notes as a reflective diary were maintained.

Data management and analysis

The collected quantitative data was transferred from the ODK to an excel spreadsheet. Upon completion of data collection, each questionnaire was assessed for its completeness. Data entry, cleaning and coding was done using Microsoft Excel program and exported to Stata software V.16.1 (College Station, Texas). Descriptive analyses were performed for proportions, percentages, means and their corresponding standard deviations.

The primary outcome variable of the study was COVID-19 risk perception which was assessed by asking a question “How do you perceive the level of risk that you have for acquiring COVID-19 infection” with responses along a six-point Likert scale ranging from “Not at all” to “Very high risk”. Thereafter, the options “not at all, very low risk, low risk, and medium risk” were categorized into “Low risk” and options “high risk and very high risk” into “High risk” for dichotomization of the provided responses. Vaccination status of the respondents was assessed by asking “Have you been vaccinated against COVID-19” with “Yes/No” responses.

Age was categorized into three options (<30 years, 30–39 years and 40+ years) whereas work experience was dichotomized at its median (<6 years, 6+ years). For categorical variables chi-square test and binary logistic regression were used to assess associations between sociodemographic characteristics and COVID-19 vaccination status to risk perceptions. Statistical significance was defined as a p value of <0.05.

For qualitative data, the audio recorded in-depth interviews and focused group discussions were transcribed verbatim into word file documents where non-verbal cues were also considered. The transcription process started within 24 hours after the conduct of the interview to allow follow-up on issues for more clarity and determination of data saturation in subsequent interviews and discussions. The transcribed transcripts were checked against the audio records by two of the research team members to ensure accuracy and quality of the data generated. Thematic analysis was applied to facilitate immersing into the data methodically and thoroughly to identify themes and patterns for gaining in-depth understanding of participants’ opinions, experiences, and risk perceptions towards COVID-19 across the dataset. The analysis process followed the five thematic analysis stages as described by Braun and Clarke, 2014 [25] to establish meaningful patterns in the data: familiarization with the data, generating initial codes, searching for themes among codes, reviewing themes and presenting the results. Through this process three main themes emerged: perceived risk of being infected; risk of infecting others and perceived reduced risk to infection due to use of COVID-19 vaccines. The coding also involved identification of the typical quotes that are used to illustrate the various themes presented in the study.

Ethical considerations

Ethical approval was obtained from the Research and Publication Committee of the Muhimbili University of Health and Allied Sciences (MUHAS-REC-08-2021-839). Permission to collect data in Regions and Councils was sought from the President’s Office Regional Administration and Local Government, Ministry of Health Community, Development, Gender, Elderly and Children (MoHCDGEC), Regional Secretariat (RS) and Local Government Authorities (LGAs). Prior to collection of data, all participants were provided with information on the purpose of the study, voluntary nature of participation, right to withdraw from study at any time without consequence and guaranteed anonymity. Signed, informed consent was obtained from all participants before enrolment into the study.

Results

A total of 1,368 HCWs were approached and involved in the quantitative part of this study. All the approached participants in health facilities consented to participate. Most of the respondents were female (60.1%) and had the mean age of 35.7 years (SD 10.1). There was almost an equal representation of participants by regions, except for Dar es Salaam which contributed the largest proportion (26.1%). Most of the respondents were from the district-level facilities (42.1%) and about three quarters (77.5%) worked in Government facilities (Table 1).

Table 1. Background characteristics of HCWs (N = 1368).

Variable Frequency Percentage
Age (years)
    <30 470 34.4
    30–39 483 35.3
    40+ 415 30.3
Sex
    Male 546 39.9
    Female 822 60.1
Education level
    Primary/Secondary 36 2.6
    Certificate 437 31.9
    Diploma 610 44.6
    Degree/Masters 285 20.8
Work experience (years)
    <6 731 53.4
    6+ 637 46.6
Region
    Dar es salaam 357 26.1
    Kilimanjaro 187 13.7
    Lindi 151 11.0
    Mbeya 186 13.6
    Njombe 158 11.5
    Simiyu 137 10.0
    Tabora 192 14.0
Health facility level
    Regional Referral Hospital 378 27.6
    District Hospital 576 42.1
    Health center 414 30.3
Facility ownership
    Government 1060 77.5
    CDH/DDH 148 10.8
    Private/NGO 160 11.7

Only about one half of the HCW (53.6%) reported to have been vaccinated whereas three quarters (75.5%) self-perceived to have a high risk of acquiring a COVID-19 infection.

Logistic regression was used to analyze the effect of perceived COVID-19 risk on the probability of being vaccinated against COVID-19. It was found that the odds of getting vaccinated increased by 1.535 (95% CI 1.197, 1.967) for the HCWs who perceived their risk of getting COVID-19 infection as high (Table 2).

Table 2. Univariate binary logistic regression model showing relationship between COVID-19 risk perception and vaccination status.

Coefficients B Std. Error Sig Exp (B) 95% CI
COVID-19 Risk .428 .127 .001 1.535 1.197, 1.967
Constant -.180 .110 .101 .835

Information on risk perceptions to COVID-19 infection during the qualitative in-depth interviews and focus group discussions revealed three main themes: risk of being infected, risk of infecting others and reduced risk to infection due to use of COVID-19 vaccines. Participants reported that they are at increased risk of being infected by COVID-19 while making a reference to the nature of their work and their working environment. It was explained that the inadequate and limited use of personal protective equipment’s (PPEs) including standard face masks and sanitizers at the health facilities elevated the perceived risks to the infection. Some of the HCWs mentioned to have attended patients several times without using any PPEs due to their frequent unavailability. Others perceived that the that the risk of being infected with COVID-19 infection was so high because even when the PPEs are available, not all HCWs comply with their use. In one of the districts, when officials explained about the working environment and the risks to being infected by COVID-19 infection said:

the risk for health care workers being infected with COVID-19 is high because of the working environment, people have relaxed, they are no longer taking measures against COVID-19, some do not bother to wear masks, wash hands, keep social distancing … even when masks are there they just don’t put it on all the time as required, everything about COVID-19 seem to have been paralyzed, no one is either complying or discussing about it, which makes the working environment unsafe (IDI1).

Working in a health facility setting was the other mentioned reason for higher perceived risk of being infected by COVID-19. Participants voiced concerns that it is the HCWs who take care of the COVID-19 patients, which increases their chance of being infected. It was said that most of the hospitals do not have enough offices or changing rooms for HCWs. This necessitates sharing of available rooms among the HCWs. This also included sharing of the same facilities with HCWs attending patients at the intensive care unit (ICU) or patients with difficulty breathing. Participants detailed that the shared rooms are small and limited in number, which was perceived as heightening their risk to COVID-19 infection. When detailing on this matter a participant during the in-depth interviews voiced that unless compliance to the recommend preventive measures is strongly reinforced, HCWs will continue to be at higher risk of being infected by COVID-19:

You cannot say health care workers are not at risk of COVID-19 as far as they are working in the hospital, they are taking care of the COVID-19 patients, they share small rooms, no dedicated rooms for those attending patients at the intensive care unit or with difficult breathing, sometimes do not have all the required PPEs so the risk is there and if one gets infected it is likely the rest will experience the same unless compliance to recommendation protective measures is high we will continue to be at higher risk of COVID-19” (IDI3)

Furthermore, concerns regarding risks of the HCWs to infect other people, including their patients was voiced. It was reported that frequently the HCWs would attend patients without having knowledge of their personal or attended patient’s COVID-19 infection status. As such, it was noted that as long as they attend patients, transmission of the infection was inevitable. This was elaborated during an in-depth interview by the health facility in-charge as follows:

Transmission of the infection is not avoidable … as long as you attend patients, a chance of acquiring or transmitting it to others still viable. First of all, you may not even be aware that you are COVID-19 positive when attending a patient because COVID-19 symptoms resemble that of other diseases like malaria such as feeling fever, joint pains, cough and so on…and the patient may have same symptoms and you think it is malaria and not COVID-19” (IDI4).

On the other hand, perceptions that the risk to COVID-19 infection has been reduced with the use of COVID-19 vaccines were also expressed. When expounding on this, participants compared the perceived risk to the infection during the first wave when people were helpless with the time when vaccines were introduced:

The risk to COVID-19 infection was very high like 100% during the first wave because COVID-19 was a new thing and we had no enough knowledge on the precautions to take or what to do, but the risk decreased during the second wave because we had enough knowledge on how this disease is transmitted and how to take precautions and the risk decreased more and more to the point that we are not that much worried because there is the introduction of vaccine which has helped us to build protection” (FGD 3)

Those respondents belonging to the oldest age group had higher proportions with a high-risk perception for acquiring COVID-19 infection compared to the younger age groups. Similarly, the proportion of respondents reporting to have been vaccinated for COVID-19 was highest within the oldest age group. Risk perception and vaccination status was also shown to vary significantly by region of the respondents. Whereas Njombe, Simiyu and Mbeya had more than 85% of the respondents perceiving their risk as high, those in Dar es Salaam only had about 60% reporting the same. On the other hand, respondents from Simiyu, Lindi and Kilimanjaro had more that 60% reporting to have been vaccinated compared to other regions which consistently had less than 50% reporting the same (Table 3).

Table 3. Socio-demographic characteristics by high COVID-19 risk perception and reporting being vaccinated for COVID-19.

Variable High Risk Perception p-value Vaccinated p-value
Age (years)
    <30 335 (71.4) 187 (39.8)
    30–39 350 (72.8) .000 271 (56.1) .000
    40+ 344 (83.3) 273 (65.8)
Sex
    Male 399 (73.5) .159 292 (53.5) 1.000
    Female 630 (76.8) 439 (53.4)
Education level
    Primary/Secondary 30 (83.3) 20 (55.6)
    Certificate 344 (78.9) .083 213 (48.7) .121
    Diploma 451 (74.4) 337 (55.2)
    Degree/Masters 204 (71.6) 161 (56.5)
Work experience (years)
    <6 529 (72.8) .012 319 (43.6) .000
    6+ 500 (78.6) 412 (64.7)
Region
    Dar es salaam 211 (59.3) 177 (49.6)
    Kilimanjaro 146 (78.1) 114 (61.0)
    Lindi 106 (70.2) .000 93 (61.6) .001
    Mbeya 157 (85.3) 87 (46.8)
    Njombe 142 (90.4) 78 (49.4)
    Simiyu 114 (83.8) 87 (63.5)
    Tabora 153 (79.7) 95 (49.5)
Health facility level
    Regional Referral Hospital 262 (69.7) 174 (46.0)
    District Hospital 454 (79.1) .004 304 (52.8) .000
    Health center 313 (75.8) 253 (61.1)
Facility ownership
    Government 777 (73.5) 612 (57.7)
    CDH/DDH 121 (81.8) .006 70 (47.3) .000
    Private/NGO 1313 (82.9) 49 (30.6)

Respondents from low and mid-level health care facilities (health centers and district hospitals, respectively) reported much higher risk perceptions compared to those in high level facilities (Regional referral hospitals). Equally, respondents in low level facilities had higher proportions of HCWs reporting to have been vaccinated compared to those in high level facilities.

Respondents working in government facilities had a lower proportion (73.5%) reporting to be at high-risk compared to those working in faith-based organizations, NGOs, and private health facilities. Contrariwise, those respondents from the government facilities had higher proportions reporting to have been vaccinated compared to their counterparts (Table 3).

Discussion

This study aimed at exploring HCWs perceptions in relation to the COVID-19 vaccine uptake to inform policy makers and highlighting targeted educational needs to address similar situations especially in developing countries like Tanzania. About a quarter of the HCW perceived to have a low risk of acquiring a COVID-19 infection. Furthermore, those with perceived low risk had higher proportions reporting to be unvaccinated for COVID-19.

In the current study, majority of the HCWs perceived risk of contracting COVID-19 to be high, consistent to a recent multi-country study that found equally high levels of COVID-19 risk perception levels in the countries [26]. Due to the nature of their daily work activities and physical proximity to potential COVID-19 cases, it was expected that the vast majority of the HCW in health facilities would consider themselves to be at a heightened risk for contracting the infection. However, consistent availability of appropriate and required PPEs would have contributed towards allaying some of the perceived risks. To control the spread of infection, it is crucial that all HCWs become sensitized to the increased risk that they are subjected to with respect to COVID-19 infection. This may ensure that necessary precautions and protective measures are adopted by the HCW and respective health facilities to prevent acquisition of infections, but more importantly, that they not become the source of infection to the patients and clients that they encounter regularly. High perceived risk of COVID-19 has largely improved the infection prevention and control behaviors of HCWs as indicated by studies in Egypt and Ethiopia [27] however, the picture was different in Tanzania where even though participants reported high perceived risk consistent use of protective gears was not reinforced, even when they were available.

It has been widely reported that high perceived risk of contracting COVID-19 is a significant predictor of vaccine acceptance [28]. We report HCWs that perceived to have a high risk for COVID-19 infection had a larger proportion reporting to have been vaccinated for COVID-19 compared to their counterpart. This is similar to results of from a review indicating that HCWs faced increased exposure to COVID-19 and hence high levels of morbidity and mortality, thereby heightening their own perception of risk, a key factor in the decision to vaccinate [29], [30]. However, current findings reveal that only about a half of the HCW had been vaccinated despite high perceived risk and sustained efforts to ensure availability and encourage vaccinations. Thus, the link between the perceived risk of COVID-19 and COVID-19 vaccine uptake was tenuous in this setting, contrary to some similar studies [31]. A study in Malawi and Ethiopia found similar results whereby perceived risk of COVID-19 infection was not associated with motivation to receive the vaccine [32, 33]. One probable explanation for this could be that a considerable proportion of people in Africa including Tanzania, consider the vaccines as unnecessary, and that alternatives to COVID-19 vaccination exist. The contextual differences in terms of political, social and cultural factors may explain such dissimilar findings [34, 35]. Many studies have indicated that when people perceive COVID-19 as a threatening disease, the demand for a vaccine against the disease would correspondingly increase. However, this study has shown this to not necessarily be the case. Other factors, especially vaccine safety concerns have been shown to outweigh the perceived disease risks in determining vaccine acceptance as indicated in a systematic review among health care workers in Africa [36]. Informing the public about the safety of a COVID-19 vaccine should be the focus for health authorities aiming to achieve a high vaccine uptake especially in Tanzania where other factors including contradicting government stance may have had an influential role in overall vaccine acceptancy.

As expected, this study showed high perceived risk for COVID-19 among older HCW which correlated with high vaccine uptake. Literature indicates that vaccine hesitancy was more common among young people than older adults partly due to their lower risk of comorbidities [3739]. Further, the observed excess mortality in the elderly population due to COVID-19 may have functioned to make this group feel particularly vulnerable, thus both enhancing their risk perception and increasing willingness to adopt protective measures. Being male has been reported to be uniformly associated with lower risk perceptions in many countries, which is consistent with other risk perception studies [40], a finding which was not corroborated in the present study. This may be due to the similarity of our participants with respect to the perceived risk of getting COVID-19 infection. That is, all HCWs have same risk for the infection, irrespective of their identified sex.

The triangulation method used in this study under mixed method design provides a deeper understanding and contextual insights of the research in question. The key informant interviews and the focused group discussions complement the quantitative findings. One major limitation relates to cross-sectional nature of current study as the vaccine was being introduced in Tanzania and following a COVID-19 surge. Attitudes and uptake may change over time as the pandemic continues and roll-out expands. Therefore, our findings should be interpreted with caution with an understanding that the situation is likely to evolve over time. The second limitation is a possibility of recall bias, particularly due to inability of using HCWs electronic COVID-19 vaccination records to confirm vaccination history. However, this limitation is not expected to greatly influence current findings due to the relatively short time between the initial vaccination roll-out and our study. Thirdly, in conducting a mixed method study there is the possibility of introducing interviewer bias. To minimize this, in addition to training, authors provided a common interviewer guide to every interviewer to enhance objectivity. Despite these limitations, findings presented provide valid and important insights into the risk perceptions of the HCWs and associated structural factors during the COVID-19 pandemic in Tanzania.

Conclusions

While majority of the HCWs perceived to have a high risk of contracting COVID-19, only about a half of respondents reported to be vaccinated. High perceived risk for COVID-19 infection, older age, female gender, working in a district hospital and a privately owned hospital were associated with increased vaccine uptake. The prevailing working environment and constant exposure to patients, rendered some HCWs to perceive their risk of contracting COVID-19 as unavoidable. However, other HCWs declared the potential role of COVID-19 vaccines in reducing their risk of infection. Health promotion activities focusing on the beneficial role of COVID-19 vaccine in reducing transmission risk may increase vaccine uptake in Tanzania.

Policy implications

A consistent and evidence-based position adopted by the health authorities is an important prerequisite towards addressing any novel public health emergency. Tackling future public health emergencies requires tailored, effective health promotion measures to encourage uptake of protective interventions. HCWs should be the primary targets of health promoting activities since they remain to be key sources of information for the general population and their personal attitudes greatly influence communities’ intervention uptake. Such deliberate and targeted health promotion actions are crucial in the context where policies allow for voluntary intervention uptake, as is the case in Tanzania.

Acknowledgments

The authors acknowledge their corresponding institutions for providing support to conduct the study. We recognize the cooperation from all the health care workers that took part in this study. We acknowledge the support from the regional and district medical and vaccine officers and the health facilities-in charges of the involved health facilities. We thank our research assistants for their dedication to conduct this study timely, namely Melina Mgongo, Doris Mbata, Oko Okong’o, Zenaice Aloyce, Martha Joseph, Mtumwa Bakari, Nyanjura Manyama, Zenais Kiwale, Anastazia Ngowi, Barikiel Panga, Novatus Tesha, Albert Majura, Naike Nathaniel, Julietha Tibyesiga, Loveness Kimaro, Judith Kokuleba, Ngusa Kalambo, Constancia F Luyenga, Monica Mtei, Jackline Ngowi, Edson B Jeremiah, Witness Simon, Erick Kazoka, Chrispin Mgute.

Data Availability

All data and related metadata underlying the findings reported in a submitted manuscript should be deposited in an appropriate public repository, Dryad with the following DOI details: https://doi.org/10.5061/dryad.vdncjsxz9

Funding Statement

This research work was supported by grant from UNICEF (MA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Singhal T. A Review of Coronavirus Disease-2019 (COVID-19). Indian J Pediatr [Internet]. 2020/03/13. 2020. Apr;87(4):281–6. Available from: https://pubmed.ncbi.nlm.nih.gov/32166607 doi: 10.1007/s12098-020-03263-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.World Health Organization(WHO). Coronavirus disease (COVID-19) Dashboard [Internet]. 2023. [cited 2023 Apr 27]. Available from: https://covid19.who.int/ [Google Scholar]
  • 3.World Health Organization (WHO). WHO Coronavirus (COVID-19) Dashboard, United Republic of Tanzania [Internet]. 2023. [cited 2023 Apr 27]. Available from: https://covid19.who.int/region/afro/country/tz [Google Scholar]
  • 4.Angelo AT, Alemayehu DS, Dachew AM. Health care workers intention to accept COVID-19 vaccine and associated factors in southwestern Ethiopia, 2021. PLoS One. 2021;16(9 September):1–15. doi: 10.1371/journal.pone.0257109 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.World Health Organization. Who Sage Roadmap for Prioritizing Uses of Covid 19 Vaccines in the Context of Limited Supply. Who; [Internet]. 2020;(September):1–13. Available from: https://apps.who.int/iris/bitstream/handle/10665/334299/WHO-2019-nCoV-SAGE_Framework-Allocation_and_prioritization-2020.1-eng.pdf [Google Scholar]
  • 6.VOA. Tanzania Publishes First COVID-19 Data in Over a Year [Internet]. 2021. [cited 2022 Jan 20]. Available from: https://www.voanews.com/africa/tanzania-publishes-first-covid-19-data-over-year [Google Scholar]
  • 7.Asabe C, Timothy C, Percy K, Mashige K, Levi Osuagwu U, Envuladu E, et al. Acceptance of COVID-19 vaccine among sub-Saharan Africans (SSA): a comparative study of residents and diasporan dwellers. BMC Public Health. 2023. Jan 28;23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.De Sousa A, Soares CP, Venuti A, La Torre G, Basak P, Abir T, et al. A global study on the correlates of gross domestic product (GDP) and COVID-19 vaccine distribution. mdpi.com. 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.WHO. Ten threats to global health in Air pollution and climate change Noncommunicable diseases [Internet]. 2019. [cited 2023 Apr 27]. Available from: https://www.who.int/news-room/spotlight/ten-threats-to-global-health-in-2019 [Google Scholar]
  • 10.Liu Q, Luo D, Haase JE, Guo Q, Wang XQ, Liu S, et al. The experiences of health-care providers during the COVID-19 crisis in China: a qualitative study. Lancet Glob Heal. 2020;8(6):e790–8. doi: 10.1016/S2214-109X(20)30204-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Ferrer R, Klein WM. Risk perceptions and health behavior. Curr Opin Psychol [Internet]. 2015. Oct 1;5:85–9. Available from: https://pubmed.ncbi.nlm.nih.gov/26258160 doi: 10.1016/j.copsyc.2015.03.012 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Barrett ES, Horton DB, Roy J, Gennaro ML, Brooks A, Tischfield J, et al. Prevalence of SARS-CoV-2 infection in previously undiagnosed health care workers in New Jersey, at the onset of the U.S. COVID-19 pandemic. BMC Infect Dis. 2020;20(1). doi: 10.1186/s12879-020-05587-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Sikkema RS, Pas SD, Nieuwenhuijse DF, O’Toole Á, Verweij JJ, van der Linden A, et al. COVID-19 in health-care workers in three hospitals in the south of the Netherlands: a cross-sectional study. Lancet Infect Dis. 2020;20(11):1273–80. doi: 10.1016/S1473-3099(20)30527-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Liao Q, Wu P, Wing Tak Lam W, Cowling BJ, Fielding R. Trajectories of public psycho-behavioural responses relating to influenza A(H7N9) over the winter of 2014–15 in Hong Kong. Psychol Health. 2019;34(2):162–180. doi: 10.1080/08870446.2018.1515436 [DOI] [PubMed] [Google Scholar]
  • 15.Deressa W, Worku A, Abebe W, Gizaw M, Amogne W. Risk perceptions and preventive practices of COVID-19 among healthcare professionals in public hospitals in Addis Ababa, Ethiopia. PLoS One. 2021;16(6):e0242471. Published 2021 Jun 25. doi: 10.1371/journal.pone.0242471 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Graffigna G, Palamenghi L, Boccia S, Barello S. Relationship between citizens’ health engagement and intention to take the covid-19 vaccine in italy: A mediation analysis. Vaccines. 2020;8(4):1–11. doi: 10.3390/vaccines8040576 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Ba MF, Faye A, Kane B, Diallo AI, Junot A, Gaye I, et al. Factors associated with COVID-19 vaccine hesitancy in Senegal: A mixed study. Hum Vaccines Immunother. 2022;18(5). doi: 10.1080/21645515.2022.2060020 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Kanu S, James PB, Bah AJ, Kabba JA, Kamara MS, Elleanor CE, et al. Healthcare Workers’ Knowledge, Attitude, Practice and Perceived Health Facility Preparedness Regarding COVID-19 in Sierra Leone. J Multidiscip Healthc. 2021;14:67. doi: 10.2147/JMDH.S287156 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Fares S, Elmnyer MM, Mohamed SS, Elsayed R. COVID-19 Vaccination Perception and Attitude among Healthcare Workers in Egypt. 2021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Detoc M, Bruel S, Frappe P, Tardy B, Botelho-Nevers E, Gagneux-Brunon A. Intention to participate in a COVID-19 vaccine clinical trial and to get vaccinated against COVID-19 in France during the pandemic. Vaccine. 2020. Oct;38(45):7002–6. doi: 10.1016/j.vaccine.2020.09.041 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Seale H, Heywood AE, Leask J, Sheel M, Durrheim DN, Bolsewicz K, et al. Examining Australian public perceptions and behaviors towards a future COVID-19 vaccine. BMC Infect Dis. 2021;21(1):1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Sallam M, Dababseh D, Eid H, Al-Mahzoum K, Al-Haidar A, Taim D, et al. High rates of covid-19 vaccine hesitancy and its association with conspiracy beliefs: A study in jordan and kuwait among other arab countries. Vaccines. 2021;9(1):1–16. doi: 10.3390/vaccines9010042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ciardi F, Menon V, Jensen JL, Shariff MA, Pillai A, Venugopal U, et al. Knowledge, Attitudes and Perceptions of COVID-19 Vaccination among Healthcare Workers of an Inner-City Hospital in New York. 2021;1–16. doi: 10.3390/vaccines9050516 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Qualitative Inquiry and Research Design | WorldCat.org [Internet]. [cited 2022 Sep 27]. Available from: https://www.worldcat.org/title/1204732188
  • 25.Braun V, Clarke V. What can “thematic analysis” offer health and wellbeing researchers? Int J Qual Stud Health Well-being [Internet]. 2014. Oct 16;9:26152. Available from: https://pubmed.ncbi.nlm.nih.gov/25326092 doi: 10.3402/qhw.v9.26152 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Dryhurst S, Schneider CR, Kerr J, Freeman ALJ, Recchia G, van der Bles AM, et al. Risk perceptions of COVID-19 around the world. J Risk Res. 2020;23(7–8):994–1006. [Google Scholar]
  • 27.Abdel Wahed WY, Hefzy EM, Ahmed MI, Hamed NS. Assessment of Knowledge, Attitudes, and Perception of Health Care Workers Regarding COVID-19, A Cross-Sectional Study from Egypt. J Community Health. 2020;45(6):1242–51. doi: 10.1007/s10900-020-00882-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Dolu İ, Turhan Z, Yalnlz Dilcen H. COVID-19 Vaccine Acceptance is associated with Vaccine Hesitancy, Perceived Risk and Previous Vaccination Experiences. Disaster Med Public Health Prep. 2023. Dec;17. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.AlShurman A, Fozia Khan A, Mac C, Majeed M, Ahmad Butt Z. What demographic, social, and contextual factors influence the intention to use COVID-19 vaccines: a scoping review. mdpi.com. 2021. doi: 10.3390/ijerph18179342 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Patterson N, Paz-Soldan V, Oberhelman R, Moses L, Madkour A, Miles T. Exploring perceived risk for COVID-19 and its role in protective behavior and COVID-19 vaccine hesitancy: a qualitative study after the first wave. BMC Public Health. 2022. Mar 15;22. doi: 10.1186/s12889-022-12900-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Solís Arce JS, Warren SS, Meriggi NF, Scacco A, McMurry N, Voors M, et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat Med. 2021;27(8):1385–94. doi: 10.1038/s41591-021-01454-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Moucheraud C, Phiri K, Whitehead HS, Songo J, Lungu E, Chikuse E, et al. Uptake of the COVID-19 vaccine among healthcare workers in Malawi. Int Health. 2023;15(1):77–84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Yilma D, Mohammed R, Abdela SG, Enbiale W, Seifu F, Pareyn M, et al. COVID-19 vaccine acceptability among healthcare workers in Ethiopia: Do we practice what we preach? Trop Med Int Heal. 2022. Apr;27(4):418–25. doi: 10.1111/tmi.13742 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Anjorin AAA, Odetokun IA, Abioye AI, Elnadi H, Umoren MV, Damaris BF, et al. Will Africans take COVID-19 vaccination? PLoS One. 2021;16(12 December):1–15. doi: 10.1371/journal.pone.0260575 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Konje E, Basinda N, Kapesa A, Konje ET, Mugassa S, Nyawale HA, et al. The Coverage and Acceptance Spectrum of COVID-19 Vaccines among Healthcare Professionals in Western Tanzania: What Can We Learn from This. mdpi.com. 2022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Ackah M, Ameyaw L, Salifu MG, Asubonteng DPA, Yeboah CO, Annor EN, et al. COVID-19 vaccine acceptance among health care workers in Africa: A systematic review and meta-analysis. PLoS One. 2022. May;17(5 May). doi: 10.1371/journal.pone.0268711 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Anjorin AA, Abioye AI, Asowata OE, Soipe A, Kazeem MI, Adesanya IO, et al. Comorbidities and the COVID-19 pandemic dynamics in Africa. Trop Med Int Heal. 2021;26(1):2–13. doi: 10.1111/tmi.13504 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Abayomi A, Osibogun A, Kanma-Okafor O, Idris J, Bowale A, Wright O, et al. Correction to: Morbidity and mortality outcomes of COVID-19 patients with and without hypertension in Lagos, Nigeria: a retrospective cohort study (Global Health Research and Policy, (2021), 6, 1, (26), 10.1186/s41256-021-00210-6). Glob Heal Res Policy. 2021;6(1). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Diop BZ, Ngom M, Pougué Biyong C, Pougué Biyong JN. The relatively young and rural population may limit the spread and severity of COVID-19 in Africa: A modelling study. BMJ Glob Heal. 2020;5(5). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Finucane ML, Alhakami A, Slovic P, Johnson SM. The affect heuristic in judgments of risks and benefits. J Behav Decis Mak. 2000;13(1):1–17. [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0001223.r001

Decision Letter 0

Edina Amponsah-Dacosta

16 Feb 2023

PGPH-D-22-01599

Health care workers’ self-perceived infection risk and COVID-19 vaccine uptake: a mixed methods study

PLOS Global Public Health

Dear Dr. Nyamuryekung'e,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

==============================

EDITOR: Kindly take careful consideration of the reviewers comments in revising your manuscript. In addition, I have the following comments consistent with those of the reviewers:

As part of the introduction study, the authors should better contextualize the study by addressing the availability of a national policy / guideline on vaccination of health care workers against preventable diseases (e.g. hepatitis B, influenza) including COVID-19. Also provide information on the current COVID-19 vaccine coverage rates within the general population, and among relevant populations groups like health care workers (globally versus regionally versus locally in Tanzania).

The authors should provide a justification for choosing thematic analysis as the most appropriate method for the data collected. Further to this, a full outline / list of the core emergent themes should be explicitly reported in the Results section.

The Discussion section as it currently stands is fairly thin. The authors should fully appraise the findings of this study against similar studies conducted in Africa and elsewhere (providing specific examples where relevant), exploring health care workers’ perceived risk of COVID-19 and uptake of COVID-19 vaccination.

The limitations of this study are not adequately addressed.  For example, the authors should address issues around recall bias and the limitation of not using health care workers’ electronic COVID-19 vaccination records/certificates to confirm vaccination history. It is also unclear to me if health care workers were asked to provide reasons for why they were not vaccinated. Is there a reason the authors chose not to collect such data.

The authors should take note of editorial and grammatical errors throughout the document and ensure that these are resolved when revising the manuscript. Examples include but are not limited to the following:

  • Line 79 pg 8; “…first nation-wise COVID 19 vaccination…” Do the authors mean “nation-wide”?

  • Inconsistency in writing COVID-19 and SARS-CoV-2

  • Lines 97 – 99 pg 9; “While being a high-risk group…associated positive protective behaviors” This sentence is unclear. Kindly rephrase for better clarity.

  • Line 235 pg 17; “The higher perceived risk to COVID 19 infection perceptions…” Please rephrase this sentence for ease of clarity.

  • Line 325 pg 21; “However, consisted availability of appropriate and required PPEs…” Please rephrase this sentence for ease of clarity.

  • Lines 375 – 377 pg 24; “Targeted information the public on the beneficial role…” Please rephrase for clarity.

Lines 82 – 83 pg 8; “A total of 2,431,769 vaccine doses administered by the end of year 2021 under COVAX facility” this sentence appears to be hanging or incomplete. No date as to when this tally was reach has been supplied.

Lines 83 – 85 pg 8; “While vaccine availability may not have been a challenging option initially…” This statement may be misleading. The challenges in availability of, and access to COVID-19 vaccines across the African region at the height of the pandemic have been widely acknowledged. Further to this, the negative far-reaching consequences of withholding vaccines from the region on vaccine acceptance and uptake at the population level may be immeasurable but existent. Please consider rephrasing this statement.

The sample size in the Abstract section is 1386 while that in the results section is 1368. Please resolve this disparity. In addition, kindly address if all health care workers invited agreed to participate in this study. In other words, what are the recruitment versus enrolment numbers for this study.

While Table 3 is presented, it is not cited within the text. Kindly make reference to Table 3 within the reference section for ease of clarity.

Lines 336 – 337 pg 22; “It has been widely reported that high perceived risk of contracting COVID 19 is a significant predictor of vaccine acceptance.” Please provide reliable references to support this statement.

Line 340 – 342 pg 22; “One probable explanation for this…people in Africa consider the vaccines as unnecessary…” Given that this was a single country, multi-site study, is this inference and generalization founded?

Line 344 – 347 pg 22; “However, this study has shown…especially vaccine safety concerns…” did the authors report on vaccine safety concerns among the study population?

I was unable to access the supplementary file “Data review URC” using the link provided.

==============================

Please submit your revised manuscript by Apr 02 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Edina Amponsah-Dacosta, Ph.D., MPH

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. In the online submission form, you indicated that your data will be submitted to the Dryad database upon acceptance. Should your submission be accepted, we will require the following information in your Data Availability Statement: 

a. The DOI provided by Dryad

b. The citation for your data package in the reference section of your manuscript

c. The citation for your data package in the methods section

If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Firstly I would like to congratulate the authors on the equality of their manuscript.

I would like to recommend if they consider using Univariate binary logistic regression to estimate the magnitude of the statistical associations and perform multivariate logistic regression to identify the predictors of SARS-CoV-2 vaccine uptake and high risk perception. In addition to controlling for potential confounders. Findings from the current study would have stronger evidence if both descriptive and analytical analysis. If vaccination dates are available analyzing risk perception per pandemic situation period would be valuable as well. In the discussion part I would recommend mentioning changes in pandemic situation between November 2021 and January 2022 which could influence COVID-19 risk perception among HWCs.

Reviewer #2: Congratulations on conducting important paper regarding Health care workers’ self-perceived infection risk and COVID-19 vaccine uptake.

The manuscript is logical and of a reasonable standard, being based on sound scientific principles. However, there are several issues (highlighted below) which have raised my concern.

1. The manuscript does not read well in some sections with many instances of poor grammar. I strongly recommend that you make use of a language editor.

2. The abstract contains abbreviations/acronyms which have not been previously defined.

3. The authors mix spellings of American English and UK English. I would suggest they stick to one style throughout

4. The data of confirmed COVID-19 cases and deaths is very dated. The same for number of vaccine doses administered under the COVAX facility. Please update with latest data

5. Acceptability, and willingness of the population to vaccinate is tautology.

6. Ensure consistency in terminology; COVID-19 versus COVID 19. SARS-CoV-2

7. Line 79, nation-wide instead of nation-wise?

8. Please add a reference to the bold statement in lines 83 – 85.

9. Add quotation marks to the definition of vaccine hesitancy (lines 104 -105).

10. Study sites – It is not clear the reason why Dar es salaam was purposefully chosen?

11. Sample size determination – what is the population from which the sample size determination (line 141-143) was determined?

12. How were HCWs chosen for participation in the study? Were all available HCWs invited to participate and interviews carried out until the minimum sample size was reached? Or were HCWs randomized for participation in the study? This is not clear.

13. HCWs was defined earlier in the manuscript. No need to use the full term thereafter.

14. Please add details about the pilot test.

15. Is there any special reason why the qualitative component of the study was not carried out in all seven regions? Why the choice of four regions instead of all regions (or the one cosmopolitan (Dar es salaam) region)?

16. Is ‘hospital in charges’ (line 157) an official designation or title in the Tanzanian health system?

17. More details about the questionnaire. What did the validated tool contain? Likert scale to measure risk perception?

18. Line 170 - ‘Consent information was administered?’ Do you mean the study information was given and consent obtained?

19. Line 175, please define the abbreviations, IDI and FDG in full.

20. It is not clear how the authors determined high risk perception and low risk perception. What was the cut-off point at which a participant can be regarded as having a high risk perception to COVID-19?

21. RESULTS – Please state the response rate of the participants.

22. RESULTS – Table 1, Intervals for the work experience (<6 and 6+) are not logical.

23. Table 2 results should be shown as Odds Ratio. This would be a more a useful result.

24. Please use the same number of decimal places for your percentages

25. More probing of participants of the qualitative arm of the study in order to document their risk behaviours, experiences, and even recommendations on how to improve the vaccine uptake and/or risk perception.

26. The Discussion is very thin. The authors missed out on an opportunity to discuss their findings and compare with many other studies carried out in Tanzania (https://www.mdpi.com/2076-393X/10/9/1429; https://iariw.org/wp-content/uploads/2022/10/Masele_Daud_IARIW-TNBS-2022-1.pdf) and other international studies such as (https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0250017; https://www.frontiersin.org/articles/10.3389/fpsyg.2020.02166/full; https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0242471; https://www.tandfonline.com/doi/full/10.2147/RMHP.S310289; https://intjem.biomedcentral.com/articles/10.1186/s12245-021-00341-0; https://www.sciencedirect.com/science/article/pii/S0195670120302784?casa_token=OvEn9vM2IzQAAAAA:umHRhFRZiScbi163sbEXlt0r6gV1ZFMAJcPpsPu979DDzqi4nhdqqjwCSH1TOEleXf2kanJp4wPg) to mention a few studies.

27. Clear recommendations should be provided based on the findings of the study.

28. The statements under the ‘Policy implications’ section of the manuscript are too general. The authors should state how future/current policy for vaccination and risk behaviours can be influenced and by the findings of the study

29. Reference #3 and #6 needs to be fixed (start with the author).

30. Add access dates to all online references

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0001223.r003

Decision Letter 1

Edina Amponsah-Dacosta

26 Apr 2023

PGPH-D-22-01599R1

Health care workers’ self-perceived infection risk and COVID-19 vaccine uptake: a mixed methods study

PLOS Global Public Health

Dear Dr. Nyamuryekung'e,

Thank you for submitting your revised manuscript to PLOS Global Public Health. After careful consideration, the reviewers feel that there are still some aspects of the manuscript that still need revision. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please take the time to carefully address these minor comments as this will be your final opportunity to submit a revised draft for consideration.

Please submit your revised manuscript by May 26 2023 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Edina Amponsah-Dacosta, Ph.D., MPH

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: All comments have been addressed

Reviewer #2: (No Response)

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #1: Yes

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: Yes

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: I thank the authors for addressing all my comments and made an adequate revision of the submitted article. I have no further comment with regards to the manuscript.

Reviewer #2: A few remarks remain unresolved. Please address the following:

1. Line 3 of the abstract; ‘healthcare’ is different for that used in the title ‘health care’. Also check Lines 80, 143, 244, 299.

2. HCWs is defined in line 80. No need to use the unabbreviated text thereafter.

3. Are the terms healthcare workers, healthcare professionals, healthcare personnel interchangeable? I recommend using health care workers throughout the manuscript.

4. Line 68-69. The data of confirmed global COVID-19 cases and deaths is very dated. Please update with latest data

5. Line 192, FGD already defined earlier.

6. Line 265, change COVID 19 to COVID-19

7. Line 299, HCWs instead of health care workers.

8. Table 2 – please double check the 95% CI values. Does not seem correct

9. Reference #2 is incomplete.

10. The authors in their response claim the following ‘A more extensive appraisal of current findings against available relevant literature has now been conducted. Several papers have been added in the related to similar papers in Africa and from recommendations provided by the reviewers.’ This is not reflected in the discussion with the same references used as in the original submission.

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Mncengeli Sibanda

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0001223.r005

Decision Letter 2

Edina Amponsah-Dacosta

8 May 2023

Health care workers’ self-perceived infection risk and COVID-19 vaccine uptake: a mixed methods study

PGPH-D-22-01599R2

Dear Dr. Nyamuryekung'e,

We are pleased to inform you that your manuscript 'Health care workers’ self-perceived infection risk and COVID-19 vaccine uptake: a mixed methods study' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Edina Amponsah-Dacosta, Ph.D., MPH

Academic Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Does this manuscript meet PLOS Global Public Health’s publication criteria? Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe methodologically and ethically rigorous research with conclusions that are appropriately drawn based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception. The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS Global Public Health does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: (No Response)

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: PLOS_Response to Reviewer_Resubmission.docx

    Attachment

    Submitted filename: PLOS_Response to Reviewers_Resub 2.docx

    Data Availability Statement

    All data and related metadata underlying the findings reported in a submitted manuscript should be deposited in an appropriate public repository, Dryad with the following DOI details: https://doi.org/10.5061/dryad.vdncjsxz9


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES